242 results
8-K
EX-10.2
03ft4fnvlszwv
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
xtm5oxcg2s5smectzk01
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
keat3 66w
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.1
huqe7dhdi6p
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.2
qif n7f5b
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
h2uht
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
yotuvcncpd
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
6vuahfyv 2j
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
fv4h199ari7r ang8d
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
ydhytohi0mh
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
EX-99.1
8cknb1vq egp8sx1
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am